Laddar...
Low dose rapamycin exacerbates autoimmune experimental uveitis.
Rapamycin, a potent immune modulator, is used to treat transplant rejection and some autoimmune diseases. Uveitis is a potentially severe inflammatory eye disease, and 2 clinical trials of treating uveitis with rapamycin are under way. Unexpectedly, recent research has demonstrated that low dose rap...
Sparad:
Huvudupphovsmän: | , , , , , , , |
---|---|
Materialtyp: | Artigo |
Språk: | Inglês |
Publicerad: |
Public Library of Science (PLoS)
2012-01-01
|
Serie: | PLoS ONE |
Länkar: | http://europepmc.org/articles/PMC3344911?pdf=render |
Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|